Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |